Biofilm EPS PIA. Staphylococcus antibiofilm agent biofilm inhibitor dispersion

Journal

Current pharmaceutical biotechnology
ISSN: 1873-4316
Titre abrégé: Curr Pharm Biotechnol
Pays: Netherlands
ID NLM: 100960530

Informations de publication

Date de publication:
2022
Historique:
received: 15 12 2020
revised: 09 05 2021
accepted: 31 05 2021
pubmed: 10 7 2021
medline: 12 2 2022
entrez: 9 7 2021
Statut: ppublish

Résumé

Formation of Staphylococcus aureus biofilm causes significant infections in the human body. Biofilm forms through the aggregation of bacterial species and brings about many complications. It mediates drug resistance and persistence and facilitates the recurrence of infection at the end of antimicrobial therapy. Biofilm formation is completed in a series of steps, and any interference in these steps can disrupt its formation. Such interference may occur at any stage of biofilm production, including attachment, monolayer formation, and accumulation. Interfering agents can act as quorum sensing inhibitors and interfere in the functionality of quorum sensing receptors, attachment inhibitors, and affect cell hydrophobicity. Among these inhibiting strategies, attachment inhibitors could serve as the best agents against biofilm formation, because in case pathogens abort the attachment, the next stages of biofilm formation, e.g., accumulation and dispersion, will fail to materialize. Inhibition at this stage leads to suppression of virulence factors and invasion. One of the best knowing inhibitors is a chelator that collects metal, Fe+, Zn+, and magnesium critical for biofilm formation. These effective factors in the binding and formation of biofilm are investigated, and the coping strategy is discussed. This review examines the stages of biofilm formation and determines what factors interfere in the continuity of these steps. Finally, the inhibition strategies are investigated, reviewed, and discussed.

Identifiants

pubmed: 34238148
pii: CPB-EPUB-116590
doi: 10.2174/1389201022666210708171123
doi:

Substances chimiques

Virulence Factors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

664-678

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Ahmad Nasser (A)

Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Mehdi Soltan Dallal (MMS)

Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Shiva Jahanbakhshi (S)

Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Taher Azimi (T)

Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Leila Nikouei (L)

Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH